About 6-[2-[(3R)-4-acetyl-3-methylpiperazin-1-yl]pyrimidin-5-yl]-1-[[1-(2-hydroxyethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]-2-methylindazol-3-one
6-[2-[(3R)-4-acetyl-3-methylpiperazin-1-yl]pyrimidin-5-yl]-1-[[1-(2-hydroxyethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]-2-methylindazol-3-one (PubChem CID 122620417) has the molecular formula C27H30F3N7O3
and a molecular weight of 557.58 g/mol. Its IUPAC name is 6-[2-[(3R)-4-acetyl-3-methylpiperazin-1-yl]pyrimidin-5-yl]-1-[[1-(2-hydroxyethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]-2-methylindazol-3-one.
Molecular Properties
| Compound Name | 6-[2-[(3R)-4-acetyl-3-methylpiperazin-1-yl]pyrimidin-5-yl]-1-[[1-(2-hydroxyethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]-2-methylindazol-3-one |
| PubChem CID | 122620417 |
| Molecular Formula | C27H30F3N7O3 |
| Molecular Weight | 557.58 g/mol |
| Exact Mass | 557.24 |
| IUPAC Name | 6-[2-[(3R)-4-acetyl-3-methylpiperazin-1-yl]pyrimidin-5-yl]-1-[[1-(2-hydroxyethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]-2-methylindazol-3-one |
| SMILES | CC(=O)N1CCN(c2ncc(-c3ccc4c(=O)n(C)n(Cc5cn(CCO)cc5C(F)(F)F)c4c3)cn2)C[C@H]1C |
| InChI | InChI=1S/C27H30F3N7O3/c1-17-13-35(6-7-36(17)18(2)39)26-31-11-20(12-32-26)19-4-5-22-24(10-19)37(33(3)25(22)40)15-21-14-34(8-9-38)16-23(21)27(28,29)30/h4-5,10-12,14,16-17,38H,6-9,13,15H2,1-3H3/t17-/m1/s1 |
| InChIKey | APESOPOFDMMJOF-QGZVFWFLSA-N |
| XLogP | 2.71 |
| TPSA | 101.42 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 557.58 |
| LogP ≤ 5 | 2.71 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Analyze 6-[2-[(3R)-4-acetyl-3-methylpiperazin-1-yl]pyrimidin-5-yl]-1-[[1-(2-hydroxyethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]-2-methylindazol-3-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 6-[2-[(3R)-4-acetyl-3-methylpiperazin-1-yl]pyrimidin-5-yl]-1-[[1-(2-hydroxyethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]-2-methylindazol-3-one?
The IUPAC name of 6-[2-[(3R)-4-acetyl-3-methylpiperazin-1-yl]pyrimidin-5-yl]-1-[[1-(2-hydroxyethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]-2-methylindazol-3-one (CID 122620417) is 6-[2-[(3R)-4-acetyl-3-methylpiperazin-1-yl]pyrimidin-5-yl]-1-[[1-(2-hydroxyethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]-2-methylindazol-3-one.
What is the SMILES notation for 6-[2-[(3R)-4-acetyl-3-methylpiperazin-1-yl]pyrimidin-5-yl]-1-[[1-(2-hydroxyethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]-2-methylindazol-3-one?
The canonical SMILES for 6-[2-[(3R)-4-acetyl-3-methylpiperazin-1-yl]pyrimidin-5-yl]-1-[[1-(2-hydroxyethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]-2-methylindazol-3-one is CC(=O)N1CCN(c2ncc(-c3ccc4c(=O)n(C)n(Cc5cn(CCO)cc5C(F)(F)F)c4c3)cn2)C[C@H]1C.
What is the InChIKey of 6-[2-[(3R)-4-acetyl-3-methylpiperazin-1-yl]pyrimidin-5-yl]-1-[[1-(2-hydroxyethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]-2-methylindazol-3-one?
The InChIKey is APESOPOFDMMJOF-QGZVFWFLSA-N. The full InChI is InChI=1S/C27H30F3N7O3/c1-17-13-35(6-7-36(17)18(2)39)26-31-11-20(12-32-26)19-4-5-22-24(10-19)37(33(3)25(22)40)15-21-14-34(8-9-38)16-23(21)27(28,29)30/h4-5,10-12,14,16-17,38H,6-9,13,15H2,1-3H3/t17-/m1/s1.
What are the key properties of 6-[2-[(3R)-4-acetyl-3-methylpiperazin-1-yl]pyrimidin-5-yl]-1-[[1-(2-hydroxyethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]-2-methylindazol-3-one?
6-[2-[(3R)-4-acetyl-3-methylpiperazin-1-yl]pyrimidin-5-yl]-1-[[1-(2-hydroxyethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]-2-methylindazol-3-one has a molecular weight of 557.58 g/mol, XLogP of 2.71, 6 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[2-[(3R)-4-acetyl-3-methylpiperazin-1-yl]pyrimidin-5-yl]-1-[[1-(2-hydroxyethyl)-4-(trifluoromethyl)pyrrol-3-yl]methyl]-2-methylindazol-3-one is sourced from PubChem (CID 122620417), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).